257 related articles for article (PubMed ID: 29751212)
1. Sustainable vaccine development: a vaccine manufacturer's perspective.
Rappuoli R; Hanon E
Curr Opin Immunol; 2018 Aug; 53():111-118. PubMed ID: 29751212
[TBL] [Abstract][Full Text] [Related]
2. Partnering for Vaccine Emerging Markets--Berlin, June 10-11, 2013: balancing vaccine quality, capacity, and cost-of-goods in emerging markets.
Onraedt A
Hum Vaccin Immunother; 2013 Sep; 9(9):2022-4. PubMed ID: 23966097
[TBL] [Abstract][Full Text] [Related]
3. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
4. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
Knobler S; Bok K; Gellin B
Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
[TBL] [Abstract][Full Text] [Related]
5. Vaccines: Shaping global health.
Pagliusi S; Ting CC; Lobos F;
Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
[TBL] [Abstract][Full Text] [Related]
6. Emergency response vaccines--a challenge for the public sector and the vaccine industry.
Milstien J; Lambert S
Vaccine; 2002 Nov; 21(1-2):146-54. PubMed ID: 12443673
[TBL] [Abstract][Full Text] [Related]
7. Strengthening global vaccine access for adolescents and adults.
Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A
Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384
[TBL] [Abstract][Full Text] [Related]
8. The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.
Shen AK
Hum Vaccin; 2009 Oct; 5(10):649-53. PubMed ID: 19713758
[TBL] [Abstract][Full Text] [Related]
9. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
[TBL] [Abstract][Full Text] [Related]
10. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
11. Next generation vaccines.
Riedmann EM
Hum Vaccin; 2011 Jul; 7(7):718-22. PubMed ID: 22002157
[TBL] [Abstract][Full Text] [Related]
12. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
[TBL] [Abstract][Full Text] [Related]
13. The art of partnerships for vaccines.
Pagliusi S; Che Y; Dong S
Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
[TBL] [Abstract][Full Text] [Related]
14. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
[TBL] [Abstract][Full Text] [Related]
15. The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade.
Robbins A; Arita I
Int J Technol Assess Health Care; 1994; 10(1):39-46. PubMed ID: 8157459
[TBL] [Abstract][Full Text] [Related]
16. Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs).
Huzair F; Borda-Rodriguez A; Upton M
OMICS; 2011 Sep; 15(9):539-43. PubMed ID: 21732822
[TBL] [Abstract][Full Text] [Related]
17. Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
Medaglini D; De Azero MR; Leroy O; Bietrix F; Denoel P
Vaccine; 2018 Feb; 36(9):1136-1145. PubMed ID: 29395517
[TBL] [Abstract][Full Text] [Related]
18. The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats.
Osterholm M; Moore K; Ostrowsky J; Kimball-Baker K; Farrar J;
Lancet Infect Dis; 2016 Jan; 16(1):e1-e9. PubMed ID: 26526664
[TBL] [Abstract][Full Text] [Related]
19. Why might regional vaccinology networks fail? The case of the Dutch-Nordic Consortium.
Hendriks J; Blume S
Global Health; 2016 Jul; 12(1):38. PubMed ID: 27388678
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
